Literature DB >> 28215279

About Training and Memory: NK-Cell Adaptation to Viral Infections.

Q Hammer1, C Romagnani2.   

Abstract

Viral infections continuously challenge and shape our immune system. Due to their fine antigen recognition ability, adaptive lymphocytes protect against pathogen reencounter by generating specific immunological memory. Innate cells such as macrophages also adapt to pathogen challenge and mount resistance to reinfection, a phenomenon termed trained immunity. As part of the innate immunity, natural killer (NK) cells can display rapid effector functions and play a crucial role in the control of viral infections, especially by the β-herpesvirus cytomegalovirus (CMV). CMV activates the NK-cell pool by inducing proinflammatory signals, which prime NK cells, paralleling macrophage training. In addition, CMV dramatically shapes the NK-cell repertoire due to its ability to trigger specific NK cell-activating receptors, and enables the expansion and persistence of a specific NK-cell subset displaying adaptive and memory features. In this chapter, we will discuss how different signals during CMV infection contribute to NK-cell training and acquisition of classical memory properties and how these events can impact on reinfection and cross-resistance.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetic; HCMV; Heterologous immunity; Ly49H; MCMV; Memory; NK cells; NKG2C; Trained immunity

Mesh:

Substances:

Year:  2016        PMID: 28215279     DOI: 10.1016/bs.ai.2016.10.001

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  30 in total

Review 1.  Immune responses to congenital cytomegalovirus infection.

Authors:  Ilija Brizić; Lea Hiršl; William J Britt; Astrid Krmpotić; Stipan Jonjić
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 2.  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Authors:  Ivayla E Gyurova; Ayad Ali; Stephen N Waggoner
Journal:  Viral Immunol       Date:  2019-12-03       Impact factor: 2.257

Review 3.  The Broad Spectrum of Human Natural Killer Cell Diversity.

Authors:  Aharon G Freud; Bethany L Mundy-Bosse; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-11-21       Impact factor: 31.745

Review 4.  Innate Immune Memory and the Host Response to Infection.

Authors:  Edward R Sherwood; Katherine R Burelbach; Margaret A McBride; Cody L Stothers; Allison M Owen; Antonio Hernandez; Naeem K Patil; David L Williams; Julia K Bohannon
Journal:  J Immunol       Date:  2022-02-15       Impact factor: 5.422

5.  Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.

Authors:  Yongjun Sui; Jianping Li; Roushu Zhang; Sunaina Kiran Prabhu; Hanne Andersen; David Venzon; Anthony Cook; Renita Brown; Elyse Teow; Jason Velasco; Jack Greenhouse; Tammy Putman-Taylor; Tracey-Ann Campbell; Laurent Pessaint; Ian N Moore; Laurel Lagenaur; Jim Talton; Matthew W Breed; Josh Kramer; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Mark G Lewis; Lai-Xi Wang; Jay A Berzofsky
Journal:  JCI Insight       Date:  2021-04-28

6.  Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.

Authors:  Costin Tomescu; Kyle Kroll; Krystal Colon; Emmanouil Papasavvas; Ian Frank; Pablo Tebas; Karam Mounzer; Roger Keith Reeves; Luis J Montaner
Journal:  Eur J Immunol       Date:  2021-06-19       Impact factor: 6.688

7.  Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56dim Natural Killer Cells.

Authors:  Laurie Lajoie; Nicolas Congy-Jolivet; Armelle Bolzec; Gilles Thibault
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 8.  Immunological memories of the bone marrow.

Authors:  Hyun-Dong Chang; Koji Tokoyoda; Andreas Radbruch
Journal:  Immunol Rev       Date:  2018-05       Impact factor: 12.988

9.  Adaptive Natural Killer Cells Integrate Interleukin-18 during Target-Cell Encounter.

Authors:  Quirin Hammer; Timo Rückert; Josefine Dunst; Chiara Romagnani
Journal:  Front Immunol       Date:  2018-01-17       Impact factor: 7.561

Review 10.  Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.

Authors:  Marisa Market; Leonard Angka; Andre B Martel; Donald Bastin; Oladunni Olanubi; Gayashan Tennakoon; Dominique M Boucher; Juliana Ng; Michele Ardolino; Rebecca C Auer
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.